These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33821673)

  • 41. Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors.
    Fu DJ; Liu SM; Li FH; Yang JJ; Li J
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1050-1059. PubMed ID: 32299262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
    J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sterically induced conformational restriction: Discovery and preclinical evaluation of novel pyrrolo[3,2-d]pyrimidines as microtubule targeting agents.
    Pavana RK; Shah K; Gentile T; Dybdal-Hargreaves NF; Risinger AL; Mooberry SL; Hamel E; Gangjee A
    Bioorg Med Chem; 2018 Nov; 26(20):5470-5478. PubMed ID: 30297118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site.
    Lin S; Du T; Zhang J; Wu D; Tian H; Zhang K; Jiang L; Lu D; Sheng L; Li Y; Ji M; Chen X; Xu H
    J Med Chem; 2022 Dec; 65(24):16372-16391. PubMed ID: 36511661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of small molecule inhibitors that interact with γ-tubulin.
    Friesen DE; Barakat KH; Semenchenko V; Perez-Pineiro R; Fenske BW; Mane J; Wishart DS; Tuszynski JA
    Chem Biol Drug Des; 2012 May; 79(5):639-52. PubMed ID: 22268380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular effects of curcumin on Plasmodium falciparum include disruption of microtubules.
    Chakrabarti R; Rawat PS; Cooke BM; Coppel RL; Patankar S
    PLoS One; 2013; 8(3):e57302. PubMed ID: 23505424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation.
    Liu W; He Y; Guo Z; Wang M; Han X; Jia H; He J; Miao S; Wang S
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2155815. PubMed ID: 36629423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation.
    Mao J; Luo QQ; Zhang HR; Zheng XH; Shen C; Qi HZ; Hu ML; Zhang H
    Chem Biol Interact; 2022 Jan; 352():109784. PubMed ID: 34932952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel sulfonate analogues of combretastatin A-4: potent antimitotic agents.
    Gwaltney SL; Imade HM; Barr KJ; Li Q; Gehrke L; Credo RB; Warner RB; Lee JY; Kovar P; Wang J; Nukkala MA; Zielinski NA; Frost D; Ng SC; Sham HL
    Bioorg Med Chem Lett; 2001 Apr; 11(7):871-4. PubMed ID: 11294380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of colchicine B-ring analogues tethered with halogenated benzyl moieties.
    Cosentino L; Redondo-Horcajo M; Zhao Y; Santos AR; Chowdury KF; Vinader V; Abdallah QM; Abdel-Rahman H; Fournier-Dit-Chabert J; Shnyder SD; Loadman PM; Fang WS; Díaz JF; Barasoain I; Burns PA; Pors K
    J Med Chem; 2012 Dec; 55(24):11062-6. PubMed ID: 23176628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.
    Wang J; Miller DD; Li W
    Drug Discov Today; 2022 Mar; 27(3):759-776. PubMed ID: 34890803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, modeling, and biological evaluation of anti-tubulin indole-substituted furanones.
    Hurysz B; Evans BA; Laryea RN; Boyer BE; Coburn TE; Dexter MS; Edwards MA; Faulkner GV; Huss RL; Lafferty MM; Manning M; McNulty M; Melvin SJ; Mitrow CM; Patel RR; Pierce K; Russo J; Seminer AM; Sockett KA; Webster NR; Cole KE; Mowery P; Pelkey ET
    Bioorg Med Chem Lett; 2023 Jun; 90():129347. PubMed ID: 37236376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
    Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
    Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrostatic contributions to colchicine binding within tubulin isotypes.
    Huzil JT; Barakat K; Tuszynski JA
    Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.
    Zhang J; Tan L; Wu C; Li Y; Chen H; Liu Y; Wang Y
    Eur J Med Chem; 2023 Feb; 248():115085. PubMed ID: 36621138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of polymethoxyphenyl-pyridines bearing amino side chains as tubulin colchicine-binding site inhibitors.
    Li X; Wu H; Feng KW; Xu J; Wu S; Zhou ZZ; Li XF
    Bioorg Med Chem; 2022 Nov; 73():117007. PubMed ID: 36150341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure-activity relationships, and molecular modelling.
    Vicente-Blázquez A; González M; Medarde M; Mollinedo F; Peláez R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2025-2044. PubMed ID: 34514909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design.
    Cheng J; Wu Y; Wang Y; Wang C; Wang Y; Wu C; Zeng S; Yu Y; Chen Q
    Biochem Biophys Res Commun; 2018 Jan; 495(1):185-188. PubMed ID: 29102632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.